Close



Mar 1, 2024 05:22AM
Feb 7, 2024 11:26AM
Feb 6, 2024 04:14PM
Feb 6, 2024 04:04PM
Feb 6, 2024 04:03PM
Feb 6, 2024 04:03PM
Feb 6, 2024 04:01PM AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Feb 6, 2024 05:40AM
Feb 5, 2024 10:07AM
Feb 1, 2024 04:00PM
Nov 8, 2023 04:01PM
Oct 31, 2023 08:05AM
Oct 31, 2023 07:58AM
Oct 31, 2023 07:10AM Amgen sales rise, but shares off as investors await obesity data
Oct 31, 2023 07:03AM
Oct 31, 2023 07:00AM
Oct 25, 2023 04:00PM
Oct 11, 2023 11:00AM
Oct 11, 2023 10:41AM
Oct 6, 2023 09:22AM
Oct 6, 2023 08:30AM Amgen (AMGN) Completes Acquisition of Horizon Therapeutics
Oct 6, 2023 08:30AM
Aug 4, 2023 08:15AM
Aug 3, 2023 04:02PM
Aug 3, 2023 04:01PM
Jul 31, 2023 04:00PM
May 8, 2023 09:30PM
May 3, 2023 09:30PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
May 1, 2023 01:45AM
Apr 28, 2023 09:00PM
Apr 28, 2023 07:33AM
Apr 27, 2023 04:02PM
Apr 27, 2023 04:01PM
Apr 23, 2023 09:00PM
Apr 21, 2023 04:00PM AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS
Apr 17, 2023 09:00PM
Apr 17, 2023 01:45AM
Apr 12, 2023 09:00PM
Apr 7, 2023 09:00PM
Apr 2, 2023 09:00PM
Mar 27, 2023 09:00PM
Mar 22, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
Mar 20, 2023 01:45AM
Mar 17, 2023 09:00PM
Mar 15, 2023 04:00PM
Jan 31, 2023 11:34PM
Jan 31, 2023 04:04PM
Jan 31, 2023 04:03PM
Jan 31, 2023 04:01PM AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
Jan 26, 2023 04:00PM

976,669 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All